Global Pharmaceutical Excipients Market is valued at approximately USD XX billion in 2021 and is anticipated to grow with a healthy growth rate of more than XX % over the forecast period 2022-2029. Pharmaceutical Excipients are inert substances used in pharmacological drugs. These are majorly used in drug formulation which adds bulkiness to solid formulations, facilitates drug absorption and enhances overall safety. The Pharmaceutical Excipients market is expanding because of factors such as the growth of the pharmaceutical market and rising generic market growth in the forecast period.

According to Statista in 2021, the global pharma sector generates revenue of around USD 1.27 trillion in 2020. It includes production, development, and research activities. In 2022, the pharmaceutical market is anticipated to generate revenue of around USD 1,109.0 billion and is expected to grow with a CAGR of around 5.23 %. Whereas rising demand and adoption for orphan drugs and the growing biosimilar market are creating lucrative opportunities for the market. However, stringent government regulations hamper the market growth in the forecast period.

The key regions considered for the Global Pharmaceutical Excipients Market study includes Asia Pacific, North America, Europe, Latin America, and Rest of the World. Europe dominated the market in terms of revenue, owing to the rising presence of pharmaceutical giants and rising consumption of excipients. Whereas Europe is deemed as the fastest-growing region in terms of the highest CAGR owing to the growing biosimilar, generics and pharmaceuticals market in the forecast period across the region.

Major market players included in this report are:

Ashland Global Holdings, Inc (US)

International Flavors & Fragrances, Inc. (US)

BASF SE (Germany)

Evonik Industries AG (Germany)

Roquette Freres (France)

Associated British Foods plc (UK)

Archer Daniels Midland Company (US)

Lubrizol Corporation (US)

Innophos Holdings (US)

Kerry Group plc (Ireland)

Recent Developments in the Market:

In May 2019, Ashland introduced the Aquaflow NMS 460E rheology modifier, a non-ionic synthetic associative thickener.
In May 2019, Colorcon introduced STARTAB, a new starch tabletting excipient designed specifically for the direct compression process.
Global Pharmaceutical Excipients Market Report Scope:

Historical Data: 2019-2020-2021

Base Year for Estimation: 2021

Forecast period: 2022-2029

Report Coverage: Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends

Segments Covered: Product, Functionality, Formulation, Region

Regional Scope: North America; Europe; Asia Pacific; Latin America; Rest of the World

Customization Scope: Free report customization (equivalent up to 8 analyst's working hours) with purchase. Addition or alteration to country, regional & segment scope*

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.

The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Product:

Organic Chemicals (Carbohydrates)

Inorganic Chemicals (Calcium Phosphate)

By Functionality:

Fillers

Binders

Lubricants

Preservatives

By Formulation:

Tablets

Capsules

Parenteral

By Region:

North America

U.S.

Canada

Europe

UK

Germany

France

Spain

Italy

ROE

Asia Pacific

China

India

Japan

Australia

South Korea

RoAPAC

Latin America

Brazil

Mexico

Rest of the World